High materiality7/10
BlossomHill Therapeutics price target raised to $40 from $30 at Guggenheim
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Guggenheim raises BLSM PT to $40; current price $25.74; priceChangeSinceSignal = 4.12.
- Guggenheim raises BLSM target to $40; price $25.74; +4.12 since signal
Key facts
- 01
Target: $40
- 02
Posted price: $25.74
- 03
Analyst firm: Guggenheim
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.